You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 8, August 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (43)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Controlled Trial of Nicotine Polacrilex Gum With Supportive Measures

Thorsteinn Blöndal, MD

Arch Intern Med. 1989;149(8):1818-1821.


Abstract

• In a placebo-controlled, double-blind, 2-year prospective study, 182 smokers were given either nicotine polacrilex gum containing 4 mg of nicotine (n=92) or a placebo (n=90). The number of participants abstinent at 2-year follow-up was 41 (44.6%) of 92 in the nicotine group vs 28 (31.1%) of 90 in the placebo group. Abstinence rates for daily nicotine gum users (n = 64) at 12 months and again at 24 months remained 48.4%, as compared with 26.1% and 31.9% for the daily placebo gum users (n = 69). Of participants with a high nicotine-dependence score, those allotted to the nicotine group rather than to the placebo group were 13 times more likely to be abstaining at the 2-year follow-up. Use of nicotine polacrilex gum, therefore, can substantially aid in stopping smoking, particularly among highly dependent smokers.

(Arch Intern Med. 1989;149:1818-1821)



Author Affiliations

From the Reykjavik (Iceland) Health Centre, Clinic for Tuberculosis and Lung Diseases.


Footnotes

Accepted for publication April 26, 1989.

Reprint requests to Clinic for Tuberculosis and Lung Diseases, Reykjavik Health Centre (Heilsuverndarstödin), Barónstigur 47, 101 Reykjavik, Iceland (Dr Blöndal).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials
Eisenberg et al.
CMAJ 2008;179:135-144.
ABSTRACT | FULL TEXT  

Nicotine replacement therapy for long-term smoking cessation: a meta-analysis.
Etter and Stapleton
Tobacco Control 2006;15:280-285.
ABSTRACT | FULL TEXT  

Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report
Balfour et al.
Eur Heart J 2000;21:438-445.
ABSTRACT  

Cost-effectiveness of the Transdermal Nicotine Patch as an Adjunct to Physicians' Smoking Cessation Counseling
Fiscella and Franks
JAMA 1996;275:1247-1251.
ABSTRACT  

Effectiveness of the 4-mg Dose of Nicotine Polacrilex for the Initial Treatment of High-Dependent Smokers
Sachs
Arch Intern Med 1995;155:1973-1980.
ABSTRACT  

Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation
Gourlay et al.
BMJ 1994;309:842-846.
ABSTRACT | FULL TEXT  

How effective is nicotine replacement therapy in helping people to stop smoking?
Tang et al.
BMJ 1994;308:21-26.
ABSTRACT | FULL TEXT  

Long-term Use of Nicotine vs Placebo Gum
Hughes et al.
Arch Intern Med 1991;151:1993-1998.
ABSTRACT  

"The Facts Concerning the Recent Carnival of Smoking in Connecticut" and Elsewhere
Williams et al.
ANN INTERN MED 1991;115:59-63.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.